Every 8-K that Healthpeak Properties Inc (DOC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow DOC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DOC filings page.
Healthpeak Properties reported solid second-quarter 2026 results, with net income applicable to common shares of $52.7 million, or $0.08 per diluted share, up from $0.05 a year earlier. Total revenues were $771,579 thousand, and diluted FFO as Adjusted remained $0.46 per share. Same-store Adjusted NOI grew 1.8% overall, driven by a 19.2% increase in Senior Housing, partially offset by a 3.2% decline in Lab. Subsidiary Janus Living delivered strong growth, with Q2 revenue of $216 million and Adjusted EBITDAre of $79 million, up 45% and 34% year over year, respectively.
Capital recycling and balance sheet actions were significant. Healthpeak generated $1.4 billion of proceeds in Q2 and through August 3, including about $1.025 billion from selling a 49% interest in an 86-asset outpatient portfolio to Brookfield at a 5.9% cap rate, plus a $400 million seller-financing repayment and $40 million of dispositions. Net Debt to Adjusted EBITDAre was 4.7x, and liquidity totaled $3.4 billion. The company repurchased 5.9 million shares for roughly $100 million, authorized a new $500 million buyback, and declared monthly dividends of $0.10167 per share for July–September, annualizing to $1.22. Full-year 2026 guidance was raised, with diluted EPS now targeted at $0.48–$0.52 and diluted FFO as Adjusted at $1.73–$1.77 per share.
Healthpeak Properties, Inc. reported strong first quarter 2026 results and raised its full-year earnings outlook. Net income applicable to common shares rose to $193.5 million, or $0.28 per share, on total revenues of $753 million. Diluted Nareit FFO was $0.42 per share and diluted FFO as Adjusted was $0.45 per share.
The quarter was driven by the successful IPO of Janus Living, which generated approximately $880 million of net proceeds and is 81.6% owned by Healthpeak. Healthpeak contributed $714 million of senior housing acquisitions to Janus and Janus reported first quarter FFO as Adjusted of $0.23 per share with revenue and Adjusted EBITDAre up 35% and 42% year over year.
Healthpeak executed $267 million of recapitalizations, dispositions, and loan repayments, including selling an 80% interest in a six-property outpatient medical portfolio to Blackstone for about $170 million, and repurchased 5.9 million shares for roughly $100 million. Net Debt to Adjusted EBITDAre was 5.4x. The company declared second quarter common dividends totaling $0.305 per share and updated 2026 guidance, lifting diluted EPS to $0.46–$0.50 and FFO as Adjusted per share to $1.71–$1.75.
Healthpeak Properties, Inc. held its annual stockholder meeting on April 30, 2026, with 632,249,628 common shares represented, about 91% of shares entitled to vote, establishing a quorum. All director nominees were elected with strong support, generally between 96.4% and 99.8% of votes cast, and the Board size was set at nine members.
Stockholders approved the advisory vote on 2025 executive compensation, with 522,635,664 votes in favor and 89.2% of votes cast supporting the proposal. They also ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 97.2% of votes cast in favor.
Healthpeak Properties, Inc. amended several credit agreements in connection with the Janus Living, Inc. IPO. The company added a new $400.0 million senior unsecured delayed draw term loan facility with a five-year maturity and increased maximum aggregate borrowing capacity under its term loan credit agreement from $1.5 billion to $2.0 billion.
Loans under the new facility bear interest at a base rate or SOFR-based rates plus a margin tied to Healthpeak OP’s debt ratings, initially 0.00% for base rate loans and 0.80% for Term SOFR and Daily SOFR loans. After these changes, unused borrowing capacity under the term loan agreement, including the delayed draw commitments, was $750.0 million.
Healthpeak Properties, Inc. filed a report stating that its President and Chief Executive Officer, Scott Brinker, is scheduled to present at the Citi 2026 Global Property CEO Conference on March 3, 2026, at 9:35 a.m. Eastern Time.
A live webcast of the presentation will be accessible through the investor relations section of Healthpeak’s website, where the accompanying presentation materials will also be posted on February 27, 2026. A replay of the presentation will remain available on the website through March 2, 2027, giving investors and other interested parties extended access.
Healthpeak Properties, Inc. filed a current report describing how it released its financial results for the fourth quarter and full year ended December 31, 2025. The company issued a press release and furnished a detailed Discussion and Reconciliation of Non-GAAP Financial Measures on its investor relations website.
Healthpeak also furnished a supplemental report with additional financial and operating information for the same period. These materials are provided as exhibits to the report and are described as being furnished, not filed, which limits their use for certain legal purposes under the federal securities laws.
Healthpeak Properties, Inc. (DOC) filed a Form 8-K announcing it furnished its financial results for the three and nine months ended September 30, 2025. The company issued a press release and provided a supplemental report and a discussion and reconciliation of non-GAAP financial measures.
The materials are available on the Investor Relations website and were furnished as Exhibits 99.1 (press release), 99.2 (supplemental report), and 99.3 (non-GAAP reconciliation). The information in Items 2.02 and 7.01 and the related exhibits was furnished, not filed, under the Exchange Act.
Healthpeak Properties, Inc. filed an 8-K that includes exhibit disclosures related to debt and legal opinions. The filing attaches the form of 4.750% Senior Notes due 2033 as Exhibit 4.1, legal opinions from Ballard Spahr LLP and Latham & Watkins LLP as Exhibits 5.1 and 5.2, and their consents included with those opinions as Exhibits 23.1 and 23.2. The document also references the Interactive Data Cover Page File and identifies Kelvin O. Moses as Chief Financial Officer for the registrant. Basic listing details such as Common Stock, $1.00 par value, and the New York Stock Exchange appear on the cover page.
Healthpeak Properties, Inc. (NYSE: DOC) filed an 8-K to report an administrative update to its February 5, 2025 shelf registration on Form S-3. Exhibit 99.1—titled “United States Federal Income Tax Considerations”—is being added and expressly supersedes the tax discussion contained in the original prospectus that forms part of the registration statement (File Nos. 333-276954-00 through -03). No new securities are being registered, and the filing does not include operating results, guidance, or transaction details. The purpose is to ensure that future securities offerings made under the shelf reflect the most current federal income tax analysis applicable to investors in the company’s REIT structure. The report was signed by CFO Kelvin O. Moses on August 5, 2025.